Zyprexa
Product Images NDC 64725-7597

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Zyprexa (NDC 64725-7597). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Tya Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (64725 7597)

Label for ZYPREXA Injection 10 mg per vial, repackaged by TYA Pharmaceuticals in Tallahassee, FL. Original manufacturer is Lilly. The label includes product NDC 0002-7597-01, lot as none, and expiration as XX-XX-XX. It instructs to see package insert for dosing information.*

FDA Label Image

Chemical Structure (Zyprexa F001 V1)

Chemical structure of ZYPREXA Intramuscular active ingredient. The diagram shows a complex heterocyclic compound with nitrogen, sulfur atoms, and methyl groups attached, reflecting the molecular arrangement characteristic of the drug's active molecule.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.